'Cost-effectiveness' - Is it always effective? [2]

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 2, 1997, Pages 286-

  Dorrian, I ^a   Tillotson, G S ^a   Lee, R M ^a  

^a Bayer plc UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CIPROFLOXACIN; IRON; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ZINC;

COST EFFECTIVENESS ANALYSIS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG USE; ENTERIC FEEDING; HUMAN; INFECTION; INTENSIVE CARE; INTRAGASTRIC DRUG ADMINISTRATION; LETTER; NASOGASTRIC TUBE; NATIONAL HEALTH SERVICE; ORAL DRUG ADMINISTRATION;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CIPROFLOXACIN; COST-BENEFIT ANALYSIS; HUMANS;

EID: 0031043859     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)